From the Research
BPC-157 is not approved by the FDA for human use and its safety and efficacy in humans have not been established through proper clinical trials, therefore, it should not be used as a medical treatment without consulting a healthcare provider. The current evidence for BPC-157 is mostly based on animal studies, which have shown its potential in healing various tissues, including tendons, muscles, and gastrointestinal tract [ 1, 2, 3, 4, 5 ]. However, these findings cannot be directly translated to humans due to the lack of clinical trials.
Key Findings
- BPC-157 has been shown to accelerate healing in animal models of muscle crush injury, tendon, ligament, and bone injuries [ 1, 2 ].
- It has also been found to be effective in healing gastrointestinal tract injuries, including ulcers and wounds [ 3, 4 ].
- The mechanism of action of BPC-157 is thought to involve promoting angiogenesis, modulating growth factors, and reducing inflammation [ 1, 3, 4 ].
Limitations
- Most research on BPC-157 has been conducted in animal models, and there is a lack of clinical trials in humans [ 1, 2, 3, 4, 5 ].
- There is no standardized dosing for BPC-157, and its quality and purity may vary when purchased online [ 1, 2, 3, 4, 5 ].
- The long-term effects and safety profile of BPC-157 in humans are unknown [ 1, 2, 3, 4, 5 ].